Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangyu Luo

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Theranostics|February 3, 2025
Erratum: Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis: ErratumTian Tian, Zhan-Hong Chen, Zongheng Zheng, et al.
Theranostics|June 3, 2020
Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasisTian Tian, Zhan-Hong Chen, Zongheng Zheng, et al.
Frontiers in Oncology|December 13, 2021
A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the ElderlySuPing Guo, FangJie Liu, Hui Liu, et al.
Journal of Cancer|April 4, 2017
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell CarcinomaShiLiang Liu, Bo Qiu, GuangYu Luo, et al.
Cell Death & Disease|July 8, 2020
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancerWendan Yu, Yijun Hua, Huijuan Qiu, et al.
Journal of Translational Medicine|June 24, 2023
Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trialGuozhen Yang, Xiaodong Su, Yuanheng Huang, et al.
International Journal of Biological Sciences|October 16, 2020
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptaseQian Long, Yijun Hua, Liru He, et al.
Nature Plants|January 26, 2024
A designer synthetic chromosome fragment functions in mossLian-Ge Chen, Tianlong Lan, Shuo Zhang, et al.
Aging|January 7, 2020
Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoterWei Jiang, Yue Yan, Manyu Chen, et al.
Molecular Oncology|December 11, 2020
SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progressionChaoliang Diao, Ping Guo, Wenjing Yang, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Theranostics|February 3, 2025
Erratum: Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis: ErratumTian Tian, Zhan-Hong Chen, Zongheng Zheng, et al.
Theranostics|June 3, 2020
Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasisTian Tian, Zhan-Hong Chen, Zongheng Zheng, et al.
Frontiers in Oncology|December 13, 2021
A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the ElderlySuPing Guo, FangJie Liu, Hui Liu, et al.
Journal of Cancer|April 4, 2017
TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell CarcinomaShiLiang Liu, Bo Qiu, GuangYu Luo, et al.
Cell Death & Disease|July 8, 2020
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancerWendan Yu, Yijun Hua, Huijuan Qiu, et al.
Journal of Translational Medicine|June 24, 2023
Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trialGuozhen Yang, Xiaodong Su, Yuanheng Huang, et al.
International Journal of Biological Sciences|October 16, 2020
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptaseQian Long, Yijun Hua, Liru He, et al.
Nature Plants|January 26, 2024
A designer synthetic chromosome fragment functions in mossLian-Ge Chen, Tianlong Lan, Shuo Zhang, et al.
Aging|January 7, 2020
Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoterWei Jiang, Yue Yan, Manyu Chen, et al.
Molecular Oncology|December 11, 2020
SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progressionChaoliang Diao, Ping Guo, Wenjing Yang, et al.
Pageof 5